Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leukemia, Promyelocytic, Acute × Diagnosis × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinal Fractures 1 Prostatic Neoplasms 1 Polyps 1 Ovarian Neoplasms 1 Osteoporosis 1 Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid 1 Focal Liver Lesions 1 Disease 1 Colorectal Neoplasms 1 Colonic Polyps 1 Colitis 1 Childhood Brain Neoplasm 1

Interventions

Arsenic Trioxide 18 Tretinoin 16 Cytarabine 10 Cyclophosphamide 9 Idarubicin 8 Filgrastim 8 Busulfan 8 fludarabine phosphate 6 Methotrexate 6 Peripheral Blood Stem Cell Transplantation 5 Etoposide 5 Tacrolimus 4 Radiotherapy 4 Gemtuzumab 4 Clofarabine 4 Antilymphocyte Serum 4 Topotecan 3 Mycophenolic Acid 3 Mitoxantrone 3 venetoclax 2 lintuzumab 2 Whole-Body Irradiation 2 Thiotepa 2 Sorafenib 2 Mercaptopurine 2 Granulocyte Colony-Stimulating Factor 2 Daunorubicin 2 Carboplatin 2 Bortezomib 2 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04562818 2020-09-24

Mexico APL

Instituto Nacional de Cancerologia de Mexico

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡